INSTITUTION'S PROFILE
Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: sdelany@wrhi.ac.za.
Publications (1)
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Journal: Lancet (London, England)
Publication date: 2022
Journal: Lancet (London, England)
Publication Year: 2022